Skip to content
Home/Companies/HealthTech/Ametris (ActiGraph)
Ametris (ActiGraph)

Ametris (ActiGraph)

HealthTech·United States·Exited 2026·Held 6yr
Entry
2020
Hold
6yr
Exit
2026

Who owns Ametris (ActiGraph)?

Ametris (ActiGraph) is an American HealthTech company, now owned by Signant Health, which acquired it in 2026 from ARCHIMED.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED Platform I · 2019 · Buyout

Key facts

HQUnited States
SectorHealthTech
Websiteametris.com
Exit Type
Trade Sale
Buyer
Signant Health
Exit Year
2026

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Carso
Active
Business ServicesFrance· 2021
Ad-Tech Medical Instrument
5.0xExited 2024
MedTechUS· 2020
to Nihon Kohden (71.4% stake via NeuroAdvanced Corp)
Namsa
Active
MedTechUS· 2020
ZYTOMICS
Zytomics
Active
MedTechGermany· 2020
Bomi Group
4.0xExited 2023
LogisticsItaly· 2019
to UPS
Direct Healthcare Group
Exited 2026
MedTechUK· 2019
to Rhone (DHCare; ARCHIMED retained minority)

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Ametris (ActiGraph)?

Ametris (ActiGraph) is now owned by Signant Health, which acquired it in 2026 from ARCHIMED.

When did Signant Health acquire Ametris (ActiGraph)?

Signant Health acquired Ametris (ActiGraph) in 2026, buying from ARCHIMED.

Who did Ametris (ActiGraph) sell to?

ARCHIMED sold Ametris (ActiGraph) to Signant Health in 2026 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue